5 In addition to the potential benefits of GLP-1 receptor agonists already mentioned, several dedicated cardiovascular outcome trials have reported positive cardiovascular and kidney outcomes with agents from the GLP-1 receptor agonist class
At that point, you are using a large portion of your syringe capacity for a single dose, and you are depleting your vial faster than necessary
A 2025 real-world safety comparison found the two drugs had distinct safety profiles, rather than one being safer overall
Think of these meds as scaffolding: they support your weight loss but dont build the whole structure
Monitoring for side effects: Patients starting semaglutide should be closely monitored for serious side effects, like: Pain in the upper part or middle of the stomach that spreads to the back Allergic reaction Decreased urination and swelling of the feet, legs, or ankles Changes in vision Fainting or dizziness Yellow eyes (jaundice), dark urine, or clay-colored stools Rapid heartbeat Sweating, confusion, drowsiness, headache, or blurred vision Customizing a treatment plan: Semaglutide should be tailored to each patients unique health profile, including their cardiovascular risk and comorbidities
If additional glycemic control is needed after at least 4 weeks on the: 0.5 mg dosage, the dosage may be increased to 1 mg once weekly
.webp)
